Confirm MONTRÉAL, June 28, 2021 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it has appointed Christine Charette to the IBEX Board of Directors. “We are extremely pleased to welcome Christine to our Board,” said Paul Baehr, IBEX Chairman and CEO. “Her wealth of experience in business development and business strategy in the biotech world will be of great value to IBEX.” Christine Charette is the Managing Partner & Founder of Scienta Advisors and Investments; she is on the Board of GlycoNet, where she serves as Chair of the Finance and Audit Committee and as a member of the Commercialization Committee, and is also on the Board of NanoMedicines Innovation Network.